title: Enhanced human CD4+ T cell engraftment in beta2-microglobulin-deficient NOD-scid mice.
abstract: Genetic crosses produced NOD/LtSz mice doubly homozygous for the severe combined immunodeficiency (scid) mutation and the beta2m (B2m) null allele. Both NOD/LtSz-scid/scid and NOD/LtSz-scid/scid B2m(null) mice lacked mature lymphocytes and serum Ig. However, homozygosity for the B2m(null) allele also resulted in the absence of MHC class I expression, loss of NK cell activity, accumulation of iron in the liver, and rapid clearance of human IgG1. NOD/LtSz-scid/scid B2m(null) mice supported markedly elevated levels of human T cell engraftment, compared with NOD/LtSz-scid/scid control animals, following injection with human PBMC. The increased engraftment was associated with a major increase in the number of human CD4+ T cells. Following injection with 20 million human PBMC, levels of human CD4+ T cells in the peripheral blood and spleen of NOD/ LtSz-scid/scid B2m(null) mice were 6- to 7-fold higher than those in NOD/LtSz-scid/scid mice and >50-fold higher than those in C.B-17-scid/scid mice. The resulting normalization of CD4+/CD8+ ratios in NOD/LtSz-scid/scid B2m(null) mice is in sharp contrast to that observed in NOD/LtSz-scid/scid mice or in C.B-17-scid/scid mice. Circulating human IgG was cleared 6-fold more rapidly in NOD/LtSz-scid/scid B2m(null) mice than in NOD/LtSz-scid/scid mice. This rapid IgG clearance suggested a failure of the engrafted human lymphoid cells to maintain high circulating levels of human IgG. The higher levels of human CD4+ T cells and the normalization of the CD4:CD8 ratio that are observed in human PBMC-engrafted NOD/LtSz-scid/scid B2m(null) mice suggest that this system may be an excellent model for studies of HIV pathogenesis.
authors.affiliation: The Jackson Laboratory, Bar Harbor, ME 04609, USA.
authors.forename: S W
authors.initials: SW
authors.lastname: Christianson
authors.forename: D L
authors.initials: DL
authors.lastname: Greiner
authors.forename: R A
authors.initials: RA
authors.lastname: Hesselton
authors.forename: J H
authors.initials: JH
authors.lastname: Leif
authors.forename: E J
authors.initials: EJ
authors.lastname: Wagar
authors.forename: I B
authors.initials: IB
authors.lastname: Schweitzer
authors.forename: T V
authors.initials: TV
authors.lastname: Rajan
authors.forename: B
authors.initials: B
authors.lastname: Gott
authors.forename: D C
authors.initials: DC
authors.lastname: Roopenian
authors.forename: L D
authors.initials: LD
authors.lastname: Shultz
mesh_terms: D000818:Animals; D016516:CD4-CD8 Ratio; D015496:CD4-Positive T-Lymphocytes / Q000276:immunology / Q000637:transplantation*; D003433:Crosses, Genetic; D006085:Graft Survival; D006801:Humans; D051379:Mice; D016688:Mice, Inbred NOD; D016513:Mice, SCID; D001613:beta 2-Microglobulin / Q000172:deficiency*
chemical_list: D001613:beta 2-Microglobulin